Clinical Outcomes of Arthroscopic Surgeries for Shoulder and Knee Sports Injuries

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age8-80
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

This observational study aims to evaluate the long-term recovery and clinical outcomes of patients undergoing minimally invasive (arthroscopic) surgeries for sports-related shoulder and knee injuries.

Sports injuries, such as ligament tears, meniscus damage, and rotator cuff tears, are common and can significantly impact a person's daily life and ability to return to sports. While surgery is an effective treatment, the recovery process and final outcomes can vary greatly from person to person.

Researchers will follow patients who are already scheduled for routine shoulder or knee surgery at the study center. By collecting detailed information about the patient's initial injury, the specific surgical techniques used by the doctor, and the patient's recovery progress over two years, the study hopes to identify which factors lead to the best healing and functional outcomes.

Participants will be asked to complete standard questionnaires about their joint function and pain levels before their surgery, and again at 6 months, 1 year, and 2 years after surgery. The study is strictly observational; it will not change the standard medical care, surgical plan, or rehabilitation routine the patients receive.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age >= 8 years.

No gender restrictions.

Definitive diagnosis of shoulder or knee sports injuries or related joint conditions.

Scheduled to undergo elective, standard-of-care surgery at the study center (procedures include but are not limited to: arthroscopic meniscus repair/meniscectomy, cartilage repair, cruciate ligament reconstruction, high tibial osteotomy [HTO], unicompartmental knee arthroplasty [UKA], arthroscopic rotator cuff repair, shoulder stabilization, and shoulder arthroplasty).

Disqualifiers

Patients requiring emergency surgery due to acute, severe trauma (e.g., open fractures, polytrauma).

Coexisting severe neurological or psychiatric diseases, or cognitive impairment that prevents understanding of the informed consent or cooperation with follow-up.

Patients in an involuntary state (e.g., under coercion).

Refusal to sign the informed consent form or refusal to participate in the study.

Trial population

The study population consists of consecutive real-world patients presenting to the sports medicine clinic or inpatient ward at the study center. These are patients who have been diagnosed with shoulder or knee joint pathologies and are scheduled to receive standard-of-care elective surgical treatments.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Standard of Care Shoulder Arthroscopy

    Procedure/Surgery

    Routine, minimally invasive arthroscopic surgical procedures tailored to the patient's specific shoulder pathology, followed by standard postoperative rehabilitation. This is strictly observational; no experimental procedures are introduced.

  • Standard of Care Knee Arthroscopy

    Procedure/Surgery

    Routine, minimally invasive arthroscopic surgical procedures tailored to the patient's specific knee pathology, followed by standard postoperative rehabilitation. This is strictly observational; no experimental procedures are introduced.

Treatment groups

500 Participants
are divided into 2 treatment groups
Group A: Shoulder Cohort1 intervention
Group B: Knee Cohort1 intervention

Trial outcomes

Primary outcomes

1

Patient-Reported Outcome Measures (PROMs) for Joint Function

Validated questionnaires evaluate function, symptoms, and QoL based on the specific cohort. 1. Higher scores indicate better outcomes (better function / less symptoms): Score 0 to 100: IKDC, Pedi-IKDC, KOOS, ACL-RSI, WOMET, Kujala AKPS, BPII 2.0, ASES, Rowe score, and EQ-5D VAS. Score 0 to 48: OSIS (Oxford Shoulder Instability) and OSS (Oxford Shoulder). Score 0 to 10: Tegner Activity Scale (higher = higher activity level). Score 0 to 16: Marx Activity Scale (higher = higher activity level). 2. Lower scores indicate better outcomes (less pain / less disability): Score 0 to 10: VAS and NRS (for pain). Score 0 to 100: Quick-DASH (upper extremity disability).

Time frame
Preoperative baseline, 2 weeks, 1 month, 6 months, 1 year, and 2 years postoperatively.

Secondary outcomes

1

Incidence of Postoperative Complications

Tracking the occurrence rate of any adverse events related to the surgery, including but not limited to surgical site infection, deep vein thrombosis (DVT), severe joint stiffness requiring manipulation, and graft failure or re-rupture requiring revision surgery.

Time frame
From the date of surgery up to 2 years postoperatively.
2

Pain Intensity Assessed by Visual Analog Scale (VAS)

Assessment of joint pain at rest and during activity using a 10-point Visual Analog Scale, where 0 represents "no pain" and 10 represents "worst imaginable pain."

Time frame
Preoperative baseline, 2 weeks, 1 month, 6 months, 1 year, and 2 years postoperatively.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.